Parenteral drug association/food and drug administration (PDA/FDA) joint regulatory conference 2026 - EO 14398
Ended Purchase Order Awarded Last action
- Contract number
- 75F40126P00266
- Awardee
-
Parenteral Drug Association, Inc. UEI KM95H38J3DR9
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $74,916
Award facts
- Contract value 100% obligated
- $74,916.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 611430 Professional and Management Development Training
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Washington, DC 20001, USA
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration issued a purchase order to Parenteral Drug Association, Inc. for $74,916.00 on September 14, 2026, to support the Parenteral Drug Association/Food and Drug Administration Joint Regulatory Conference 2026 under Executive Order 14398. Place of performance is Washington, DC. The order carries a firm fixed price structure with an ultimate completion date of September 16, 2026. No small business set-aside applies.
Quick answers
Who was awarded contract 75F40126P00266?
75F40126P00266 was awarded to Parenteral Drug Association, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 14, 2026.
How much is contract 75F40126P00266 worth?
The government has obligated $74,916 on 75F40126P00266.
Was contract 75F40126P00266 competed?
The extent of competition for 75F40126P00266 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award